We Are

Reinventing Infection Detection

Detecting Pathogens Takes Too Long

Our patented CAPTURE (Confirm Active Pathogens Through Unamplified RNA Expression) technology solves this problem, and we are now developing a portable instrument to screen for hundreds of pathogens within an hour for less than $20.


GeneCapture's unique approach to disease diagnostics uses rapid RNA-based technology to bring infection detection to the Point of Care; whether that’s a hospital bed, an airport, a cruise ship, or a battlefield.


Pathogen ID and Rapid Antibiotic Susceptibility Testing (AST)


GeneCapture scientists were successful in implementing a trained software algorithm to automatically ID seven pathogens found in complex wounds. Follow-on experiments in one hour indicated which of several antibiotics were effective in stopping the growth of the identified bacteria. The experiments were part of a Phase I SBIR with the Defense Health Agency to explore methods for bringing wound pathogen identification and treatment outside of a laboratory to the point of care. Canvas Inc. supported the project with software engineering.

COVID Research

The GeneCapture team is developing a rapid COVID 19 detection system by modifying its core technology to detect Sars-CoV-2 on a paper strip.  We are working with several of our partners to build and validate this solution.  If successful, it will provide a detection in 25 minutes.  Stay tuned for developments.  


CAPTURE Technology

Using direct RNA hybridization and optical sensing, our validated pathogen detection and antibiotic sensitivity test provides rapid results for on-site, real-time decision making. 

Partner Portal